ESR1 and breast carcinoma: Furthermore, using a gain-of-function approach in ERα-positive breast cancer cells, we showed that 2-fold CARM1 overexpression in MCF7 cells led to growth inhibition, activation of differentiation markers and inhibition of anchorage-independent growth (8).